Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment.
第一作者:
Takeyuki,Hiramatsu
第一单位:
Department of Nephrology, Aichi Welfare Cooperative Agricultural Federation, Konan-Kosei Hospital, Konan, Aichi, Japan.
作者:
主题词
老年人(Aged);白蛋白尿(Albuminuria);二苯甲基化合物(Benzhydryl Compounds);血糖(Blood Glucose);血压(Blood Pressure);糖尿病, 2型(Diabetes Mellitus, Type 2);糖尿病肾病(Diabetic Nephropathies);女(雌)性(Female);肾小球滤过率(Glomerular Filtration Rate);葡糖苷类(Glucosides);人类(Humans);肠促胰岛素类(Incretins);肾(Kidney);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies);时间因素(Time Factors);治疗结果(Treatment Outcome);心室功能, 左(Ventricular Function, Left)
DOI
10.1177/1479164120971220
PMID
33371732
发布时间
2021-05-04
- 浏览0
Diabetes & vascular disease research
1479164120971220页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文